Stock Ticker

  • Loading stock data...

Sandoz Of Novartis AG (NYSE:NVS) Acquires Antibiotics Of GlaxoSmithKline Plc (NYSE:GSK) For $500 Million

Novartis AG (NYSE:NVS)’s Sandoz entered a deal with GlaxoSmithKline Plc (NYSE:GSK) to acquire the established antibiotic brands like Fortum, Zinacef, and Zinnat for $350 million. GlaxoSmithKline will also receive milestone payments of up to $150 million. The deal will be closed by the end of this year. Sandoz decided to purchase antibiotics brands after it […]